Home : News : Rabeprazole_Medis_launch

Rabeprazole launch

It is never a dull moment for the Medis launch team, now just 2 weeks after the launch of Riluzole, Medis is successfully launching Rabeprazole with five customers in the following markets: Italy, Spain & France at the day of patent expiry.
Rabeprazole is the generic equivalent of Janssens´s brand Pariet® (brand name used in Europe, Brazil, Canada, Japan, Russia & Australia). Rabeprazole is an antiulcer drug in the class of proton pump inhibitors used to treat duodenal ulcers and erosive or ulcerative gastro esophageal reflux disease (GERD).

Go Back Send Print